STEGER; Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for STEGER; Matthias.The latest application filed is for "new compounds and their use as therapeutically active substances in the treatment and/or prevention of diseases involving the retinal pigment epithelium".

Company Profile

5.7.10

STEGER; Matthias - Zurich CH
Steger; Matthias - St. Gallen CH
Steger; Matthias - Gallen CH
Steger, Matthias - Zuerich CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Compounds And Their Use As Therapeutically Active Substances In The Treatment And/or Prevention Of Diseases Involving The Retinal Pigment Epithelium App 20220110921 - STEGER; Matthias ; et al.	2022-04-14
Compounds For Use As Therapeutically Active Substances In The Treatment And/or Prevention Of Neuroretinal Diseases App 20220089547 - STEGER; Matthias ; et al.	2022-03-24
N-(4-(oxazol-5-yl)phenyl) Chromane-3-carboxamide Derivatives And Related Compounds As Stimulators Of The Production Of Retinal Precursor Cells For The Treatment Of Neuroretinal Diseases App 20220089583 - STEGER; Matthias ; et al.	2022-03-24
Compounds for use as therapeutically active substances in the treatment of retinal diseases Grant 10,807,973 - Steger , et al. October 20, 2	2020-10-20
Compounds for use as therapeutically active substances in the treatment of retinal diseases Grant 10,752,593 - Steger , et al. A	2020-08-25
Compounds For Use As Therapeutically Active Substances In The Treatment Of Retinal Diseases App 20200207749 - STEGER; Matthias ; et al.	2020-07-02
Compounds For Use As Therapeutically Active Substances In The Treatment Of Retinal Diseases App 20200207719 - STEGER; Matthias ; et al.	2020-07-02
2-sulfanyl-benzoimidazol-1-yi-acetic acid derivatives as CRTH2 antagonists Grant 8,273,740 - Fretz , et al. September 25, 2	2012-09-25
Guanidine derivatives and their use as neuropeptide FF receptor antagonists Grant 7,727,979 - Caroff , et al. June 1, 2	2010-06-01
2-Sulfanyl-Benzoimidazol-1-Yl-Acetic Acid Derivatives as Crth2 Antagonists App 20080108638 - Fretz; Heinz ; et al.	2008-05-08
Guanidine derivatives and their use as neuropeptide ff receptor antagonists App 20060194788 - Caroff; Eva ; et al.	2006-08-31
Pyrrolidone carboxamides Grant 7,067,549 - Isler , et al. June 27, 2	2006-06-27
Pyridine and pyrimidine derivatives Grant 7,022,718 - Boehringer , et al. April 4, 2	2006-04-04
Pyrrolidone carboxamides App 20050192292 - Isler, Markus ; et al.	2005-09-01
Pyridine and pyrimidine derivatives App 20050143405 - Boehringer, Markus ; et al.	2005-06-30
Pyridine and pyrimidine derivatives Grant 6,867,205 - Boehringer , et al. March 15, 2	2005-03-15
Pyridine and pyrimidine derivatives App 20030216382 - Boehringer, Markus ; et al.	2003-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.